Hospital Formulary Status
Yes (PO solid, PO power for susp)
In-Hospital Cost
Will be updated
PharmaCare Formulary Status
Yes (PO solid, PO susp)
Special Authority
Yes (PO solid, PO susp) (See below under Restricted Use Criteria)
PharmaCare Coverage
30mg PO - $1.6986/cap
45mg PO - $2.6139/cap
75mg PO - $3.3674/cap
6mg/ml PO susp recon - $0.3570/ml
15mg/ml (30ml) - $1.2816/ml
15mg/ml (40ml) - $1.1717/ml
15mg/ml (50ml) - $1.1058/ml
Outpatient Cost
30mg PO - $1.79-2.42/cap
45mg PO - $2.91/cap
75mg PO - $3.40-4.25/cap
6mg/ml PO susp recon - $0.36-0.39/ml
Treatment and prophylaxis of influenza
Special Authority Status: Yes (PO solid, PO susp)
Special Authority Category: Limited Coverage Drugs
Special Authority Criteria: For the treatment and prophylaxis of influenza A and B during an outbreak situation among permanent residents of licensed residential care facilities (PharmaCare Plan B)
OR
For the treatment of patients at high risk* with influenza infection within 48 hrs of symptom onset, who have either:
*Please refer to the BC Special Authority Program Website for more info
Special Authority Approval Period: 5-day treatment course during influenza season
Special Authority Practitioner Exemptions: None
Special Authority Special Notes:
Gastritis (PO)
Neuropsychiatric effects (PO)
Severe skin reactions (PO)
No significant
Antimicrobial class: Antiviral, Neuraminidase Inhibitor
Pregnancy category: C
Higher doses have not been shown to be superior but may be considered in critically ill or obese patients i.e. 150mg PO BID
Average serum half life: 2.0 hr
Lung penetration: Therapeutic